| Literature DB >> 34157102 |
Kyle T Powers1, Flint Stevenson-Jones1, Sathish K N Yadav1, Beate Amthor2,3, Joshua C Bufton1, Ufuk Borucu1, Dakang Shen1, Jonas P Becker2,3, Daria Lavysh2,3, Matthias W Hentze3,4, Andreas E Kulozik2,3, Gabriele Neu-Yilik2,3, Christiane Schaffitzel1.
Abstract
Deciphering translation is of paramount importance for the understanding of many diseases, and antibiotics played a pivotal role in this endeavour. Blasticidin S (BlaS) targets translation by binding to the peptidyl transferase center of the large ribosomal subunit. Using biochemical, structural and cellular approaches, we show here that BlaS inhibits both translation elongation and termination in Mammalia. Bound to mammalian terminating ribosomes, BlaS distorts the 3'CCA tail of the P-site tRNA to a larger extent than previously reported for bacterial ribosomes, thus delaying both, peptide bond formation and peptidyl-tRNA hydrolysis. While BlaS does not inhibit stop codon recognition by the eukaryotic release factor 1 (eRF1), it interferes with eRF1's accommodation into the peptidyl transferase center and subsequent peptide release. In human cells, BlaS inhibits nonsense-mediated mRNA decay and, at subinhibitory concentrations, modulates translation dynamics at premature termination codons leading to enhanced protein production.Entities:
Year: 2021 PMID: 34157102 PMCID: PMC8287960 DOI: 10.1093/nar/gkab532
Source DB: PubMed Journal: Nucleic Acids Res ISSN: 0305-1048 Impact factor: 16.971